There were more than 330 venture capital firms that invested in at least one digital health deal in 2015, according to the report. In addition, digital health continues to account for 7% of total venture funding. Two of the six largest deals this year were by consumer-driven genetic companies, 23andMe and Helix, both deals reaching at least $100 million.